I am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model validation, stress testing, and regulatory finance, developing a deep expertise in both fundamental and technical analysis. Alongside my research partner (also my wife), I co-author investment research, com ...

Core Viewpoint - The analysis of CrowdStrike (CRWD) indicates that the primary concern is not the quality of the business but rather the valuations, which are seen as a limiting factor for investment decisions [1] Group 1: Business Quality and Valuation - The analyst expresses confidence in the business quality of CrowdStrike but is hesitant about the current valuations, suggesting that multi-year strong execution assumptions are embedded in the stock price [1] Group 2: Analyst Background - The analyst has over 20 years of experience in quantitative research, financial modeling, and risk management, with a focus on equity valuation, market trends, and portfolio optimization [1] - Previous experience includes a role as Vice President at Barclays, leading teams in model validation, stress testing, and regulatory finance, which contributes to a deep expertise in both fundamental and technical analysis [1] - The analyst collaborates with a research partner to provide high-quality, data-driven insights, emphasizing a blend of rigorous risk management and a long-term perspective on value creation [1]

Christian Mueller-Glissmann, CFA +44(20)7774-1714 | christian.mueller- glissmann@gs.com Goldman Sachs International Andrea Ferrario +44(20)7552-4353 | andrea.ferrario@gs.com Goldman Sachs International Alessandro Giglio +44(20)7051-6240 | alessandro.giglio@gs.com Goldman Sachs International Giovanni Ferrannini +44(20)7051-2589 | giovanni.ferrannini@gs.com Goldman Sachs International 9 February 2026 | 5:06AM GMT Portfolio Strategy Research GOAL POST 10 Questions for multi-asset investors early in 2026 Peter ...

Kinross Gold Corporation ( KGC ) is interestingly poised within the miners' pack today. At a time when gold prices are already elevated and margins across the industry are wide, KGC is using peak cycle cash flows to strengthenI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I ...

Last time I covered Premium Brands ( PBH:CA ), I ran the numbers on management’s $10 billion revenue goal for FY 2027 and got to about $110 per share already discounted to present value.I’m an equity analyst and founder of Goulart’s Restaurant Stocks, a research firm focused on the U.S. restaurant industry — from quick-service and fast casual to fine dining and niche concepts. I lead all thematic research and valuation efforts, applying advanced financial modeling, sector-specific KPIs, and strategic insigh ...

Core Insights - The ProShares Bitcoin ETF (BITO) is viewed as a viable option for investors seeking a balance between direct Bitcoin investments and income generation from the ETF [1] Group 1: Company Overview - The article discusses the ProShares Bitcoin ETF (BITO) and its role in the investment landscape, particularly as a middle ground for investors [1] Group 2: Analyst Background - The analyst has over 20 years of experience in quantitative research, financial modeling, and risk management, with a focus on equity valuation and market trends [1] - The analyst previously held a Vice President position at Barclays, leading teams in model validation and stress testing, indicating a strong background in both fundamental and technical analysis [1] Group 3: Research Approach - The research approach combines rigorous risk management with a long-term perspective on value creation, focusing on macroeconomic trends, corporate earnings, and financial statement analysis [1]

Group 1 - The article emphasizes the importance of quantitative research, financial modeling, and risk management in equity valuation and market trends to identify high-growth investment opportunities [1] - The experience of the analyst includes leading teams in model validation, stress testing, and regulatory finance, showcasing a strong background in both fundamental and technical analysis [1] - The collaboration between the analyst and their research partner aims to deliver high-quality, data-driven insights, focusing on macroeconomic trends, corporate earnings, and financial statement analysis [1]

Core Insights - The article discusses Bristol Myers Squibb (BMY) and highlights concerns regarding the Eliquis patent cliff, legacy erosion, and execution risks, which were significant factors when the stock was near 5-year lows in October 2025 [1]. Company Analysis - Bristol Myers Squibb is facing challenges related to the expiration of the Eliquis patent, which could impact revenue streams significantly [1]. - The company has been under scrutiny for its legacy products and the potential erosion of market share as competition increases [1]. - Execution risks are noted as a critical factor that could affect the company's operational performance and overall market position [1]. Investment Perspective - The article emphasizes the importance of evaluating valuations and dividend offerings as part of the investment analysis for Bristol Myers Squibb [1]. - The author suggests that despite the challenges, there may be potential investment opportunities if the company can navigate these risks effectively [1].

Core Viewpoint - The base case for Nvidia (NVDA) over the next 6-12 months is expected to be range-bound to moderately upward biased, rather than experiencing another sharp rerating phase after a multi-month time correction and several sentiment shifts [1]. Group 1: Company Analysis - Nvidia is anticipated to maintain a stable performance trajectory, reflecting a cautious optimism in the market outlook [1]. - The analysis suggests that Nvidia's stock may not see drastic changes in valuation but could experience gradual growth [1]. Group 2: Analyst Background - The analyst has over 20 years of experience in quantitative research, financial modeling, and risk management, focusing on equity valuation and market trends [1]. - The analyst has a background as a former Vice President at Barclays, leading teams in model validation and stress testing, indicating a strong foundation in both fundamental and technical analysis [1].

Core Insights - The analyst maintains a "Hold" stance on Dow (DOW), indicating a cautious outlook despite previous steep corrections observed by June 2025, focusing on potential balance sheet stress until a turnaround occurs [1]. Group 1: Analyst Background - The analyst has over 20 years of experience in quantitative research, financial modeling, and risk management, emphasizing equity valuation, market trends, and portfolio optimization [1]. - Previously served as Vice President at Barclays, leading teams in model validation, stress testing, and regulatory finance, showcasing expertise in both fundamental and technical analysis [1]. - Co-authors investment research with a partner, combining strengths to deliver high-quality, data-driven insights, with a focus on macroeconomic trends, corporate earnings, and financial statement analysis [1].